• May 1, 2025

Join MabPlex at BIO Boston 2025

• January 20, 2025

MabPlex Facilitates Commercialization of Teruisi’s TRS005 Program with Successful Execution of PPQ Milestone

• January 20, 2025

MabPlex Launches Commercial ADC Drug Product Fill/Finish Line

• November 25, 2024

MabPlex Congratulates Partner Shanxi Naan on Successful ADC Filing

• October 17, 2024

MabPlex Launches PFS Fill/Finish Line

• September 24, 2024

MabPlex Congratulates Salubris on the EMA Approval of their JK06 IND Filing

• October 25, 2019

Development of Robust Processes for Large Scale ADC

• October 24, 2019

MabPlex Earns Frost and Sullivan Award

• March 6, 2016

Cancer Drugs by the Sea